Efficacy of the Once-Daily Tacrolimus Formulation LCPT Compared to the Immediate-Release Formulation in Preventing Early Post-Transplant Diabetes in High-Risk Kidney Transplant Patients: A Randomized, Controlled, Open-Label Pilot Study (EUDRACT: 2017-000718-52).

Although differences at 3 months did not reach statistical significance, the mean measured GFR was 6.2 mL/min higher in the LCPT arm ( Table 2 ).

also in 111,027 other papers

The LCPT group showed a trend toward higher tacrolimus exposure at the end of the study [trough levels: IR-Tac group 8.3 (6.9–9.2) vs.

also in 53,322 other papers